Unpublished data from a retrospective study have raised concerns about the risk of cancer in patients using becaplermin [Regranex].

Author：

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1297, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy: Results from a Retrospective Hospital-Based Cohort Study

By Berg Maarten J. ten > Shantakumar Sumitra

Drug Safety, Vol. 34, Iss. 12, 2011-12 ,pp. : 1151-1160

Adis International

Access to resources Recommend Favorite

Comparison of Hyperkalemic Risk in Hospitalized Patients Treated with Different Angiotensin Receptor Blockers: A Retrospective Cohort Study Using a Korean Clinical Research Database

By Park Inwhee

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 255-262

Adis International

Access to resources Recommend Favorite

Is there a relationship between becaplermin use and cancer?

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Approaches to Missing Data Inference Results from CaPSURE: An Observational Study of Patients with Prostate Cancer

By Lubeck D.P.

PharmacoEconomics, Vol. 15, Iss. 2, 1999-02 ,pp. : 197-204

Adis International

Access to resources Recommend Favorite

Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study

By Chapman Richard H.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 299-308

Adis International

Access to resources Recommend Favorite